First CRISPR-Based Therapies For Sickle Cell Disease and Beta Thalassemia Approved In The UK

First CRISPR-Based Therapies For Sickle Cell Disease and Beta Thalassemia Approved In The UK

The gene-therapy-based treatment called Casgevy was recently approved in the UK, making it the first time that a treatment based on the CRISPR-Cas9 gene editing tool has been authorized for medical t… [+2589 chars]

Read More